Codexis (CDXS) Assets Average (2011 - 2026)
Codexis (CDXS) recorded quarterly Assets Average of $138.6 million in Q1 2026, up 1.99% quarter-over-quarter from $135.9 million in Q4 2025, and little changed on a YoY basis from $138.9 million in Q1 2025.
Codexis (CDXS) Assets Average (2011 - 2026) Analysis & Trends
Codexis' Assets Average history runs 16 years deep, the most recent figure standing at $138.6 million for Q1 2026.
- In Q1 2026, Assets Average changed 0.26% year-over-year to $138.6 million; the TTM figure through Mar 2026 stood at $138.6 million (changed 0.26% YoY), while the FY2025 annual figure was $148.4 million, up 3.93% from the prior year.
- Assets Average was $138.6 million for Q1 2026 at Codexis, up from $135.9 million in the prior quarter.
- In the past five years, Assets Average ranged from a high of $242.8 million in Q4 2022 to a low of $131.1 million in Q3 2025.
- Historically, Assets Average has averaged $175.1 million across 5 years, with a median of $145.5 million in 2023.
- The sharpest annual moves came in 2022 and 2023: Assets Average increased 11.03% in 2022, then slumped 40.08% in 2023.
- A 5-year view of Assets Average shows it stood at $242.8 million in 2022, then plunged by 40.08% to $145.5 million in 2023, then rose by 2.12% to $148.6 million in 2024, then dropped by 8.56% to $135.9 million in 2025, then rose by 1.99% to $138.6 million in 2026.
- The last three Assets Average figures came in at $138.6 million (Q1 2026), $135.9 million (Q4 2025), and $131.1 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | 33.42 Mn |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | 795.91 Mn |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | 13.04 Mn |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | 1.72 Bn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | 40.89 Mn |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | 26.03 Mn |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | 10.06 Mn |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | 26.06 Bn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | 660.38 Mn |
| 10 | Codexis | 236.00 Mn | 170.86 Mn | 13.18 Mn | 138.58 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 138.58 Mn |
| Dec 31, 2025 | 135.88 Mn |
| Sep 30, 2025 | 131.10 Mn |
| Jun 30, 2025 | 133.57 Mn |
| Mar 31, 2025 | 138.95 Mn |
| Dec 31, 2024 | 148.60 Mn |
| Sep 30, 2024 | 140.09 Mn |
| Jun 30, 2024 | 140.78 Mn |
| Mar 31, 2024 | 143.06 Mn |
| Dec 31, 2023 | 145.51 Mn |
| Sep 30, 2023 | 180.61 Mn |
| Jun 30, 2023 | 212.41 Mn |
| Mar 31, 2023 | 234.23 Mn |
| Dec 31, 2022 | 242.84 Mn |
| Sep 30, 2022 | 235.13 Mn |
| Jun 30, 2022 | 235.12 Mn |
| Mar 31, 2022 | 240.83 Mn |
| Dec 31, 2021 | 236.97 Mn |
| Sep 30, 2021 | 219.93 Mn |
| Jun 30, 2021 | 212.24 Mn |